Stada CEO Calls For Dialogue As Satisfaction With European Health Systems Declines

Almost half of Europeans are now dissatisfied with their national health systems, a recent survey by Stada finds. Company CEO Peter Goldschmidt urges for dialogue with governments and health ministries to see how self-care can help “build resilient health systems for the years to come.”

• Source: Shutterstock

Dialogue between the consumer health industry and government is crucial to reverse the continuing decline in satisfaction with health systems among European citizens, argues Stada Arzneimittel CEO Peter Goldschmidt.

Speaking at the launch of the 2024 Stada Health Report, which finds satisfaction with healthcare systems at an “all-time low,” Goldschmidt said that “open dialogue, based on empirical data” was key to “building resilient health systems for the years to come.”

Only 56% of respondents to Stada’s latest survey of 46,033 people across 23 European countries, conducted by Human8, said they were satisfied with the public health system in their country.

“Europeans’ satisfaction with their national healthcare systems is falling. Indeed, barely one in two Europeans is now happy with the level of service they receive, down from three in four satisfied citizens just five years ago,” Goldschmidt commented.

“I’m not really surprised, the trend is obvious,” Goldschmidt added. “People in these countries are waiting for answers but the answers are not there.”

Access Key

Across Europe, difficulties in getting doctors’ appointments were cited as a major reason for this dissatisfaction, followed by a general lack of trust in health authorities, privatization of public health systems and lack of access to preventative health services.

Satisfaction dropped most notably in the UK, with the country losing 11 percentage points since Stada’s last heath report in 2023 – “likely fueled by post-pandemic pressure on the UK National Health Service,” the company suggested – and in Germany, which lost nine percentage points in the year. (Also see "Over A Quarter Of EU Consumers Increase Supplement Intake But Financial Pressures Take Toll" - HBW Insight, 20 September, 2023.)

In countries where levels of satisfaction remain high, like Belgium, Switzerland and the Netherlands, by contrast, access to healthcare professionals, affordable medicines and preventative health services were cited as positives.

In Belgium, Stada has an active dialogue with the local health ministry, Goldschmidt noted.

Self-Care Solution

Given the link to availability of medicines and preventative health services, satisfaction with healthcare systems “could be linked to regular self-care,” Stada suggests in its report.

“People who regularly engage in self-care are more likely to be happy with the healthcare system than those who reportedly do little to support their own health,” the company writes.

The good news is that 89% of Europeans currently engage in activities to support their overall wellbeing. Behind physical exercise and healthy eating, taking vitamins and nutritional supplements is one of the most popular such activities.

Just under a third of Europeans surveyed by Stada said they take such products, with VMS use in the Czech Republic, Slovakia and Poland higher than average.

More from Europe

Over The Counter: What To Expect From The 61st AESGP Annual Meeting, With Jurate Švarcaite

 
• By 

HBW Insight speaks to AESGP director general Jurate Švarcaite about what's on the agenda for the upcoming 61st AESGP Annual Meeting, which will take place in Warsaw, Poland, between 2-4 June. Highlights include the role of prevention in self-care, discussions about how regulators will ensure the competitiveness of European industry on the world stage and incoming changes to sustainability legislation.

‘Nothing Unexpected’ In Third Failed Application For OTC Sildenafil In Germany

 
• By 

“Overall, no unexpected/new data or findings” were presented to Germany's Expert Committee for Prescription in the most recent Rx-to-OTC switch application for sildenafil (25mg and 50mg), according to medicines regulator BfArM, resulting in a third rejection in three years.

AESGP Slams ‘Deeply Concerning And Discriminatory’ EU Wastewater Directive

 
• By 

“Protecting the environment is a shared responsibility. It is unfair to expect only two sectors to fund wastewater treatment modernization and operation,” argues AESGP director general Jurate Švarcaite.

New Product Launches Ensured Growth For Stada CHC In 2024

 
• By 

Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.

More from Geography

New Product Launches Ensured Growth For Stada CHC In 2024

 
• By 

Like many European firms, Stada Arzneimittel's 2024 earnings were held back by a soft cough, cold and flu season. However, key launches in its home market Germany and in the Middle East offset this impact and led to 3% organic growth for Stada's Consumer Healthcare business.

Maxwellia Launches UK TV Campaign For Evana Showing Reality Of Menstruation

 
• By 

Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”

Over The Counter: Women’s Health Innovation And Beyond, With Maxwellia’s Anna Maxwell

 
• By 

HBW Insight catches up with Maxwellia CEO Anna Maxwell to discuss her company's journey so far, and what she sees as the opportunities for Rx-to-OTC switch in UK women's health and beyond.